Griffin Asset Management Inc. decreased its stake in shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Free Report) by 9.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,245,355 shares of the medical research company’s stock after selling 135,299 shares during the period. Griffin Asset Management Inc. owned 5.65% of Accelerate Diagnostics worth $2,130,000 at the end of the most recent reporting period.
Accelerate Diagnostics Stock Up 8.7 %
Shares of NASDAQ:AXDX opened at $1.87 on Wednesday. The company has a market cap of $41.24 million, a P/E ratio of -0.46 and a beta of 0.61. The business has a fifty day simple moving average of $1.72 and a 200-day simple moving average of $1.31. Accelerate Diagnostics, Inc. has a 52 week low of $0.73 and a 52 week high of $6.39.
Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The medical research company reported ($0.50) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.05. The company had revenue of $2.99 million during the quarter, compared to analyst estimates of $3.00 million. Sell-side analysts expect that Accelerate Diagnostics, Inc. will post -2.14 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
View Our Latest Research Report on AXDX
About Accelerate Diagnostics
Accelerate Diagnostics, Inc, an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.
Read More
- Five stocks we like better than Accelerate Diagnostics
- How to Calculate Return on Investment (ROI)
- Analysts Reaffirm Bullish Outlook on Global Payments Stock
- What is a Stock Market Index and How Do You Use Them?
- 3 Election Momentum Stocks You Might Have Missed
- EV Stocks and How to Profit from Them
- Tesla Stock Likely Heading Lower After RoboTaxi Flop
Want to see what other hedge funds are holding AXDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Free Report).
Receive News & Ratings for Accelerate Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accelerate Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
